Neuroimmune signatures in chronic low back pain subtypes.
chronic pain
functional connectivity
glial cells
inflammation
neuropathic
Journal
Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537
Informations de publication
Date de publication:
29 04 2022
29 04 2022
Historique:
received:
01
05
2021
revised:
11
07
2021
accepted:
24
08
2021
pubmed:
17
9
2021
medline:
3
5
2022
entrez:
16
9
2021
Statut:
ppublish
Résumé
We recently showed that patients with different chronic pain conditions (such as chronic low back pain, fibromyalgia, migraine and Gulf War illness) demonstrated elevated brain and/or spinal cord levels of the glial marker 18-kDa translocator protein (TSPO), which suggests that neuroinflammation might be a pervasive phenomenon observable across multiple aetiologically heterogeneous pain disorders. Interestingly, the spatial distribution of this neuroinflammatory signal appears to exhibit a degree of disease specificity (e.g. with respect to the involvement of the primary somatosensory cortex), suggesting that different pain conditions may exhibit distinct 'neuroinflammatory signatures'. To explore this hypothesis further, we tested whether neuroinflammatory signal can characterize putative aetiological subtypes of chronic low back pain patients based on clinical presentation. Specifically, we explored neuroinflammation in patients whose chronic low back pain either did or did not radiate to the leg (i.e. 'radicular' versus 'axial' back pain). Fifty-four patients with chronic low back pain, 26 with axial back pain [43.7 ± 16.6 years old (mean ± SD)] and 28 with radicular back pain (48.3 ± 13.2 years old), underwent PET/MRI with 11C-PBR28, a second-generation radioligand for TSPO. 11C-PBR28 signal was quantified using standardized uptake values ratio (validated against volume of distribution ratio; n = 23). Functional MRI data were collected simultaneously to the 11C-PBR28 data (i) to functionally localize the primary somatosensory cortex back and leg subregions; and (ii) to perform functional connectivity analyses (in order to investigate possible neurophysiological correlations of the neuroinflammatory signal). PET and functional MRI measures were compared across groups, cross-correlated with one another and with the severity of 'fibromyalgianess' (i.e. the degree of pain centralization, or 'nociplastic pain'). Furthermore, statistical mediation models were used to explore possible causal relationships between these three variables. For the primary somatosensory cortex representation of back/leg, 11C-PBR28 PET signal and functional connectivity to the thalamus were: (i) higher in radicular compared to axial back pain patients; (ii) positively correlated with each other; (iii) positively correlated with fibromyalgianess scores, across groups; and finally (iv) fibromyalgianess mediated the association between 11C-PBR28 PET signal and primary somatosensory cortex-thalamus connectivity across groups. Our findings support the existence of 'neuroinflammatory signatures' that are accompanied by neurophysiological changes and correlate with clinical presentation (in particular, with the degree of nociplastic pain) in chronic pain patients. These signatures may contribute to the subtyping of distinct pain syndromes and also provide information about interindividual variability in neuroimmune brain signals, within diagnostic groups, that could eventually serve as targets for mechanism-based precision medicine approaches.
Identifiants
pubmed: 34528069
pii: 6370954
doi: 10.1093/brain/awab336
pmc: PMC9128369
doi:
Substances chimiques
Receptors, GABA
0
TSPO protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1098-1110Subventions
Organisme : NINDS NIH HHS
ID : R01 NS094306
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS095937
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS087472
Pays : United States
Organisme : NIH HHS
ID : S10 OD023517
Pays : United States
Informations de copyright
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
J Neurosci. 2015 Mar 18;35(11):4552-70
pubmed: 25788673
Pain Med. 2021 Sep 8;22(9):2050-2056
pubmed: 33674851
Pain. 2021 May 1;162(5):1352-1363
pubmed: 33230008
Mol Psychiatry. 2021 Mar;26(3):864-874
pubmed: 31138890
Behav Res Methods. 2008 Aug;40(3):879-91
pubmed: 18697684
Ann Neurol. 2018 Jun;83(6):1186-1197
pubmed: 29740862
Neurology. 2016 Dec 13;87(24):2554-2561
pubmed: 27837005
Trends Immunol. 2015 Oct;36(10):605-613
pubmed: 26431938
Brain Res. 2009 Aug 25;1286:42-52
pubmed: 19555675
Science. 2011 Sep 9;333(6048):1456-8
pubmed: 21778362
Neuroimage Clin. 2018 Aug 09;20:357-364
pubmed: 30112276
Neurosci Lett. 2014 Apr 17;565:30-8
pubmed: 24406153
J Neuroinflammation. 2019 Jul 9;16(1):140
pubmed: 31288837
Pain. 2021 Apr 1;162(4):1241-1249
pubmed: 33065737
Pharmacol Ther. 2008 Apr;118(1):1-17
pubmed: 18374421
J Neuroimmunol. 2001 Mar 1;114(1-2):48-56
pubmed: 11240015
J Pain. 2006 Nov;7(11):816-22
pubmed: 17074623
J Neurosci. 2013 Jan 23;33(4):1540-51
pubmed: 23345228
Eur Radiol. 2012 Aug;22(8):1776-88
pubmed: 22752524
Nature. 2003 Aug 14;424(6950):778-83
pubmed: 12917686
J Nucl Med. 2011 Jan;52(1):154-61
pubmed: 21189415
J Cereb Blood Flow Metab. 2010 Sep;30(9):1608-18
pubmed: 20424634
Neuroimage. 2007 Aug 1;37(1):90-101
pubmed: 17560126
Phys Med Biol. 2013 Oct 21;58(20):7081-106
pubmed: 24052021
Brain Res Brain Res Rev. 1995 Mar;20(3):269-87
pubmed: 7550361
J Exp Med. 2018 Jul 2;215(7):1789-1801
pubmed: 29941548
Malays J Med Sci. 2006 Jul;13(2):11-8
pubmed: 22589599
Semin Neurol. 2018 Dec;38(6):634-639
pubmed: 30522138
Arthritis Rheum. 2009 Jun 15;61(6):715-6
pubmed: 19479689
Curr Pain Headache Rep. 2019 Mar 11;23(3):23
pubmed: 30854609
Life Sci. 1993;52(1):107-18
pubmed: 8380214
Lancet Neurol. 2012 Jul;11(7):629-42
pubmed: 22710756
J Pain. 2013 Dec;14(12):1585-600
pubmed: 24135431
Neuron. 2013 Jan 9;77(1):10-8
pubmed: 23312512
J Neurosci. 2001 Sep 1;21(17):6480-91
pubmed: 11517237
Neuroimage Clin. 2015 Jan 19;7:409-14
pubmed: 25685708
J Neurosci Res. 2017 Jun;95(6):1330-1335
pubmed: 27574286
Anesthesiology. 2013 Dec;119(6):1434-43
pubmed: 24343289
J Rheumatol. 2011 Jun;38(6):1113-22
pubmed: 21285161
Neuropsychopharmacology. 1993 Jun;8(4):305-14
pubmed: 8390266
Nat Rev Neurosci. 2014 Jan;15(1):43-53
pubmed: 24281245
Physiol Rev. 2014 Oct;94(4):1077-98
pubmed: 25287860
Neuroimage Clin. 2017 Oct 25;17:347-353
pubmed: 29159046
R Soc Open Sci. 2020 Jun 17;7(6):200260
pubmed: 32742693
J Neurophysiol. 1999 Jul;82(1):272-82
pubmed: 10400956
Eur J Pain. 2007 Feb;11(2):223-30
pubmed: 16545974
J Nucl Med. 2014 Nov;55(11):1825-30
pubmed: 25278515
Exp Neurol. 2012 Apr;234(2):351-3
pubmed: 22269389
J Nucl Med. 2007 Dec;48(12):2072-9
pubmed: 18006619
Eur J Pharmacol. 2008 Dec 28;601(1-3):79-87
pubmed: 18952075
Brain Behav Immun. 2019 Jan;75:72-83
pubmed: 30223011
Neurosci Lett. 2007 Jan 16;411(3):200-5
pubmed: 17127001
Physiol Rev. 2011 Apr;91(2):461-553
pubmed: 21527731
Neurology. 2019 Apr 23;92(17):e2038-e2050
pubmed: 30918090
Brain Behav Immun. 2020 Jul;87:498-507
pubmed: 32027960
J Nucl Med. 2018 Jan;59(1):107-114
pubmed: 28818984
J Pharmacol Sci. 2017 Jul;134(3):158-165
pubmed: 28669596
Neuroimage. 2008 Mar 1;40(1):43-52
pubmed: 18093844
Exp Neurol. 2012 Apr;234(2):271-82
pubmed: 21893056
Arthritis Care Res (Hoboken). 2010 May;62(5):600-10
pubmed: 20461783
J Nucl Med. 2015 May;56(5):701-6
pubmed: 25766898
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7900-5
pubmed: 27357684
Brain. 2015 Mar;138(Pt 3):604-15
pubmed: 25582579
J Neurochem. 1985 Aug;45(2):621-5
pubmed: 2861251
Curr Med Res Opin. 2006 Oct;22(10):1911-20
pubmed: 17022849
Nat Rev Neurosci. 2019 Nov;20(11):667-685
pubmed: 31537912
Mol Pain. 2009 Jul 01;5:35
pubmed: 19570201
J Pharmacol Exp Ther. 2003 Aug;306(2):624-30
pubmed: 12734393
ACS Chem Neurosci. 2018 Nov 21;9(11):2563-2571
pubmed: 29719953
Neuroscience. 2000;97(1):113-23
pubmed: 10771343
J Neurosci. 1999 May 1;19(9):3649-55
pubmed: 10212323
Neuroreport. 2001 Nov 16;12(16):3439-42
pubmed: 11733686
Exp Neurol. 1993 Oct;123(2):271-83
pubmed: 8405289
J Neurosci. 2006 Apr 19;26(16):4308-17
pubmed: 16624951
J Nucl Med. 2011 Dec;52(12):1914-22
pubmed: 22080447
Synapse. 2013 Dec;67(12):909-12
pubmed: 23666806
J Cereb Blood Flow Metab. 2012 Jan;32(1):1-5
pubmed: 22008728
J Med Chem. 2008 Jan 10;51(1):17-30
pubmed: 18067245
Curr Opin Pharmacol. 2016 Feb;26:16-25
pubmed: 26431645
Pain. 2018 May;159(5):968-977
pubmed: 29419657
Naunyn Schmiedebergs Arch Pharmacol. 1985 Feb;328(4):454-60
pubmed: 2986017
Acta Anaesthesiol Taiwan. 2013 Jun;51(2):73-80
pubmed: 23968658
Neurosci Lett. 2011 Jul 8;498(2):138-42
pubmed: 21571034
Pain. 2005 May;115(1-2):71-83
pubmed: 15836971